Translational Health Science and Technology Institute, Faridabad, Haryana, India.
Department of Biotechnology, Kumaun University, Nainital, Uttarakhand, India.
Scand J Immunol. 2024 Feb;99(2):e13345. doi: 10.1111/sji.13345. Epub 2023 Dec 6.
COVID-19 disease has plagued the world economy and affected the overall well-being and life of most of the people. Natural infection as well as vaccination leads to the development of an immune response against the pathogen. This involves the production of antibodies, which can neutralize the virus during future challenges. In addition, the development of cellular immune memory with memory B and T cells provides long-lasting protection. The longevity of the immune response has been a subject of intensive research in this field. The extent of immunity conferred by different forms of vaccination or natural infections remained debatable for long. Hence, understanding the effectiveness of these responses among different groups of people can assist government organizations in making informed policy decisions. In this article, based on the publicly available data, we have reviewed the memory response generated by some of the vaccines against SARS-CoV-2 and its variants, particularly B cell memory in different groups of individuals.
COVID-19 疾病困扰着世界经济,影响了大多数人的整体福祉和生活。自然感染和接种疫苗都会导致针对病原体的免疫反应的产生。这涉及到抗体的产生,这些抗体可以在未来的挑战中中和病毒。此外,记忆 B 细胞和 T 细胞的细胞免疫记忆的发展提供了持久的保护。免疫反应的持久性一直是该领域的一个研究热点。不同形式的疫苗接种或自然感染所带来的免疫程度长期以来一直存在争议。因此,了解不同人群的这些反应的有效性可以帮助政府组织做出明智的政策决策。在本文中,我们根据公开数据,回顾了一些针对 SARS-CoV-2 及其变体的疫苗产生的记忆反应,特别是不同人群的 B 细胞记忆。